| 1 |
35405009 | A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer. | 2022 Jun 6 |
1 |
| 2 |
35579133 | Enzalutamide Overcomes Dihydrotestosterone Induced Chemo-Resistance In Triple-Negative Breast Cancer Cells via Apoptosis. | 2022 May 9 |
2 |
| 3 |
33542074 | Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies. | 2021 Apr 15 |
2 |
| 4 |
32782617 | Inhibition of Rac1 reverses enzalutamide resistance in castration-resistant prostate cancer. | 2020 Sep |
1 |
| 5 |
31228231 | Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide. | 2019 Aug |
2 |
| 6 |
31297844 | The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells. | 2019 Oct |
1 |